Agilent Technologies, Inc. $A Stock Holdings Decreased by Pictet Asset Management Holding SA

Key Points

• Pictet Asset Management Holding SA cut its stake in Agilent Technologies by 11.3%, selling 593,337 shares and now holding 4,664,881 shares (about 1.65% of the company) valued at roughly $634.8 million.
• Agilent slightly missed quarterly estimates with EPS of $1.36 versus $1.37 and revenue of $1.80 billion (up 7% year-over-year), and provided FY2026 guidance of EPS 5.900–6.040 and Q2 guidance of 1.390–1.420.
• Wall Street shows a consensus "Buy" rating with an average price target of $163.71, although several firms recently lowered targets while Evercore upgraded to "outperform."

Pictet Asset Management Holding SA lessened its stake in Agilent Technologies, Inc. (NYSE:A - Free Report) by 11.3% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 4,664,881 shares of the medical research company's stock after selling 593,337 shares during the quarter. Pictet Asset Management Holding SA owned approximately 1.65% of Agilent Technologies worth $634,770,000 as of its most recent filing with the SEC.

A number of other hedge funds have also bought and sold shares of A. Brighton Jones LLC lifted its holdings in Agilent Technologies by 6.1% during the 4th quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company's stock worth $626,000 after buying an additional 270 shares during the last quarter. Jones Financial Companies Lllp increased its holdings in shares of Agilent Technologies by 15.9% in the 1st quarter. Jones Financial Companies Lllp now owns 5,610 shares of the medical research company's stock valued at $602,000 after acquiring an additional 769 shares during the last quarter. Geneos Wealth Management Inc. raised its position in shares of Agilent Technologies by 54.8% during the 1st quarter. Geneos Wealth Management Inc. now owns 599 shares of the medical research company's stock valued at $70,000 after acquiring an additional 212 shares in the last quarter. Acadian Asset Management LLC raised its position in shares of Agilent Technologies by 16.5% during the 1st quarter. Acadian Asset Management LLC now owns 5,352 shares of the medical research company's stock valued at $625,000 after acquiring an additional 758 shares in the last quarter. Finally, Sivia Capital Partners LLC bought a new position in Agilent Technologies during the second quarter worth $273,000.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on A shares. Wells Fargo & Company decreased their price objective on shares of Agilent Technologies from $175.00 to $165.00 and set an "overweight" rating for the company in a report on Thursday, February 26th. Evercore raised shares of Agilent Technologies from an "in-line" rating to an "outperform" rating and increased their target price for the stock from $155.00 to $160.00 in a report on Monday, January 5th. Weiss Ratings reaffirmed a "hold (c+)" rating on shares of Agilent Technologies in a report on Monday, December 29th. UBS Group lowered their price objective on shares of Agilent Technologies from $180.00 to $165.00 and set a "buy" rating for the company in a research report on Thursday, February 26th. Finally, Morgan Stanley dropped their price objective on shares of Agilent Technologies from $180.00 to $160.00 and set an "overweight" rating on the stock in a research note on Tuesday, March 3rd. Two investment analysts have rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, the company has a consensus rating of "Buy" and a consensus price target of $163.71.

Agilent Technologies Trading Up 0.0%

Shares of A stock opened at $115.60 on Monday. Agilent Technologies, Inc. has a 1 year low of $104.10 and a 1 year high of $160.27. The firm has a market capitalization of $32.67 billion, a PE ratio of 25.52, a price-to-earnings-growth ratio of 2.43 and a beta of 1.30. The stock has a fifty day moving average of $117.25 and a two-hundred day moving average of $133.13. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.59 and a current ratio of 2.07.

Agilent Technologies (NYSE:A - Get Free Report) last issued its quarterly earnings results on Wednesday, February 25th. The medical research company reported $1.36 EPS for the quarter, missing analysts' consensus estimates of $1.37 by ($0.01). Agilent Technologies had a net margin of 18.26% and a return on equity of 24.49%. The business had revenue of $1.80 billion for the quarter, compared to analyst estimates of $1.81 billion. During the same period last year, the business posted $1.31 earnings per share. Agilent Technologies's revenue for the quarter was up 7.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. As a group, research analysts expect that Agilent Technologies, Inc. will post 5.95 EPS for the current year.

Agilent Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, April 22nd. Shareholders of record on Tuesday, March 31st were paid a dividend of $0.255 per share. The ex-dividend date of this dividend was Tuesday, March 31st. This represents a $1.02 annualized dividend and a yield of 0.9%. Agilent Technologies's dividend payout ratio (DPR) is presently 22.52%.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company's product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.